Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: The 336 merged reexam decision

Just some info...

"35 U.S.C. 305 Conduct of reexamination proceedings.
After the times for filing the statement and reply provided for by
section 304 of this title have expired, reexamination will be
conducted according to the procedures established for initial
examination under the provisions of sections 132 and 133 of this
title. In any reexamination proceeding under this chapter, the patent owner will be permitted to propose any amendment to his patent and a new claim or claims thereto, in order to distinguish the invention as claimed from the prior art cited under the provisions of section 301 of this title, or in response to a decision adverse to the patentability of a claim of a patent. No proposed amended or new claim enlarging the scope of a claim of the patent will be permitted in a reexamination proceeding under this chapter. All reexamination proceedings under this section, including any appeal to the Board of Patent Appeals and Interferences, will be conducted with special dispatch within the Office."

1
Jun 23, 2008 01:47PM
3
Jun 23, 2008 01:52PM
1
Jun 23, 2008 01:57PM
2
Jun 23, 2008 01:59PM
6
Jun 23, 2008 02:23PM

Jun 23, 2008 02:44PM
3
Jun 23, 2008 02:53PM

Jun 23, 2008 03:25PM
3
Jun 23, 2008 03:30PM

Jun 23, 2008 05:26PM
1
Jun 23, 2008 06:33PM
4
Jun 23, 2008 08:54PM
2
Jun 24, 2008 04:12AM
5
Jun 24, 2008 06:22AM
3
Jun 24, 2008 06:40AM
5
Jun 24, 2008 06:46AM
3
Jun 24, 2008 07:05AM
2
Jun 24, 2008 07:09AM
5
Jun 24, 2008 07:19AM
2
Jun 24, 2008 07:28AM
4
Jun 24, 2008 07:45AM
3
Jun 24, 2008 08:14AM
2
Jun 24, 2008 08:29AM
Share
New Message
Please login to post a reply